Antigen Peptide CMV IE1 – HLA-B*0801 (ELRRKMMYM)

Unlock Precise Research with Antigen Peptide CMV IE1 – HLA-B0801

Designed for researchers and scientists aiming to excel in immunological studies, the Antigen Peptide CMV IE1 – HLA-B0801 (ELRRKMMYM) provides unmatched precision and reliability in cytomegalovirus (CMV) and peptide interactions. With a carefully synthesized structure tailored to the HLA-B0801 allele, this peptide supports advanced, targeted experiments in the lab.

Optimal Quality for Consistent Results

Manufactured under stringent quality standards, the Antigen Peptide CMV IE1 ensures purity, stability, and consistency for high-level research applications. Whether you’re studying T-cell epitopes related to CMV or investigating immune responses, this peptide is engineered to deliver exceptional performance while minimizing variability.

Applications in Immunology and Cellular Studies

The Antigen Peptide CMV IE1 – HLA-B0801 is ideally suited for scientific investigations involving antigen presentation, vaccine development, and immunological assays. Its compatibility with the HLA-B0801 allele contributes to its efficacy in exploring CMV-specific immune dynamics, paving the way for breakthroughs in both basic and applied biology fields.